ESR1 and neoplasm: TP53 mutations were present in both ER+ and ER− cases, although more frequent in ER− than ER+ tumours (P=5 × 10−3, Fisher's exact test), and HER2-enriched and basal than luminal subtypes (P=5 × 10−6, Fisher's exact test) as previously observed29, 30.